CRP and Hypoalbuminemia: In oncological malignancies, biochemical and hematological markers were used to assess the impact of the systemic inflammatory response on outcomes such as increased C-reactive protein (CRP) concentration, increased white cell, neutrophil, and platelet counts, and hypoalbuminemia [12].